全球

在这些国家请与我们的经销商联系

raybet欧洲Smith+Nephew完成肢体矫形外科收购

Titan™反肩系统

2021年1月4日

raybet欧&#raybet投注27954;全球医疗技术公司Smith+Nephew宣布,已完成对Integra LifeSciences Holdings Corporation(纳斯达克:IART)的Extremity orthopopaedics业务的收购,收购价格为2.4亿美元。

此次收购支持了Smith+Nephew投资于高增长raybet欧洲领域的战略。这将显著加强Smith+Nephew的四肢业务,通过增加一个集中的raybet欧洲销售渠道,互补的肩关节置换和上下肢组合,以及一个令人兴奋的新产品管道的组合。这包括下一代肩关节置换系统,预计将在2022年全面商用发射。

Smith+Nephew全球整形外科主席Skip Kiil说:raybet欧洲

“我们很高兴能在快速增长的终端领域确保这一成熟的全球业务。它的组合,专业的销售渠道和产品管道都加强了我们的业务,我们期待着欢迎我们的新同事加入Smith+Nephew。”raybet欧洲

询盘

投资者

安德鲁•斯威夫特

+44 (0) 1947433

raybet欧洲

媒体

查尔斯·雷诺兹

+44 (0) 2377314

raybet欧洲

Susan Gilchrist / Ayesha Bharmal

+44 (0) 20 7404 5959

不伦瑞克

史密斯+侄子raybet欧洲

rayberaybet投注t欧洲Smith+Nephew是一个投资组合医疗技术企业,通过使用技术来恢复人们的身体和他们的自信。我们称这种目的为“生命无限”。我们的17,500多名员工每天都在履行这一使命,通过我们卓越的产品组合,以及 我们的三个全球特许经营机构——骨科、高级伤口管理和运动医学&耳鼻喉科——的新技术的发明和应用,改变患者 的生活。我们于1856年在英国赫尔成立,目前业务遍及100多个国家,2019年年销售额达51亿美元。raybet欧洲Smith+Nephew是FTSE100成分股(伦敦证交所:SN,纽约证交所:SNN)。除非上下文另有要求,“集团”和“史密斯+外甥”raybet欧洲用于指史密斯与外甥股份有限公司 及其合并子公司。

欲了解更多关于Smith+Nephew的信息,请访问 raybet欧洲www.gushitin.com关注我们 推特, LinkedIn, Instagram或 脸谱网

前瞻性陈述

本文件可能包含前瞻性陈述,该陈述可能准确,也可能不准确。例如,关于预期收入增长和交易利润率、市场趋势和我们的产品管道的报表都是前瞻性的报表。短语,如“目标”,“计划”,“打算”,“预期”,“恰当的”,“相信”,“估计”,“期望”,“目标”,“考虑”和类似的表达通常用于确定前瞻性陈述。前瞻性陈述涉及已知和未知的风险、不确定性和其他可能导致实际结果与陈述所表达或暗示的有重大差异的重要因素。对于Smraybet欧洲ith+Nephew来说,这些因素包括:与COVID-19影响相关的风险,如其影响的深度和持久性、政府为应对而采取的行动和其他限制性措施、选择性手术的实质性延误和取消、医疗设施的程序能力下降、销售代表进入医疗设施的限制等,raybet投注或因COVID-19疫情而执行业务连续性计划的能力;我们服务的市场的经济和金融状况,特别是那些影响到医疗保健提供者、支付方和客户(包括但不限于COVID-19)的经济和金融状况;已建立和创新医疗设备的价格水平;raybet投注医疗技术的发展;raybet投注 regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers (including, without limitation, as a result of COVID-19); competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.

◊Smith商标+侄子raybet欧洲某些商标已在美国专利和商标局注册。